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TO THE EDITOR
Exposure to UV radiation is the major
factor for the development of non-
melanoma skin cancer, including squa-
mous cell and basal cell carcinoma.
The initial event in UV carcinogenesis
upon photon absorption by DNA is the
formation of cyclobutane pyrimidine
dimers (CPDs), and to a lesser extent,
pyrimidine-pyrimidone 6,4-photopro-
ducts. When these photoproducts are
left unrepaired or misrepaired, they can
lead to mutations in critical genes
such as the tumor suppressor gene p53
(Benjamin et al., 2008). However, depen-
ding on the dose of UVB exposure
and the amount of DNA photoproducts,
damaged cells undergo apoptosis or
survive through cellular repair mecha-
nisms (Clydesdale et al., 2001; Schwarz
and Schwarz, 2009), preventing or
allowing mutations to be formed from
unrepaired photoproducts. UVB-induced
DNA damage also serves as a trigger
for immunosuppression via the secretion
of IL-10 and tumor necrosis factor-a,
inhibition of dendritic cell function and
induction of regulatory T cells (Tregs;
Schwarz and Schwarz, 2009, 2011).
Certain cytokines may increase the
repair of DNA damage by stimulating
nucleotide excision repair (NER). For
instance, exogenous administration of
IL-12 and IL-23 was able to abrogate
the immunosuppressive effect of UVR
through induction of NER (Cline and
Hanawalt, 2003; Schwarz and Schwarz,
2009). It has been demonstrated that
CD80/CD86–CD28/CD152 signaling
has an important role in the prevention
of UVB-induced immunosuppression
and tumor formation (Beissert et al.,
1999; Loser et al., 2005). However, the
individual role of CD28 has not been
investigated in short-term UV effects,
including DNA damage. Here, we have
targeted CD28 with small interfering
RNA (siRNA) to determine the role of
this signaling pathway in the preservation
of UVB-induced skin alterations.
Mice were exposed to 80 mJ cm2
UVB (a moderate dose, as previously
determined (Pflegerl et al., 2009) imme-
diately after CD28 siRNA or control
siRNA injection (Figure 1a), and skin
samples were collected at 1, 6, and
24 hours after UVB exposure for hema-
toxylin and eosin and immunohisto-
chemical thymine dimer staining. We
found similar number of thymine dimers
(a specific form of CPDs), positive cells
and sunburn cells (SBC), in the epider-
mis of CD28 siRNA- and control siRNA-
injected mice 1 and 6 hours after UVBAccepted article preview online 16 September 2013; published online 31 October 2013
Abbreviations: CPD, cyclobutane pyrimidine dimer; NER, nucleotide excision repair; Treg, regulatory T cell
TP Singh et al.
In Vivo CD28 Knockdown
www.jidonline.org 861
ICR-CD1R
UVB (80 mJ cm–2)
CD28 siRNA or control siRNA given
immediately before UVB exposure
Sunburn cells
N
on
e
None
UVB UVB
UVBUVB
None
CT
 s
iR
NA
CD
28
 s
iR
NA
CPD formation
45 None
***
*** *
***
UVB
None
UVB
40
35
30
25
20
15
10
N
um
be
r o
f s
un
bu
rn
 c
el
ls
5
0
0
CD28 siRNA
Mean nuclear intensity
1 3
ICR-CD1R
5 7 9 11 13 15 17 19 21 23
1
0
4
*
*
* *
3
2
CO
X2
 (fo
ld 
ch
an
ge
)
1
0
4
5
6
7
CD4
CD28 siRNA+UVB
100
100
101
101
102
102
103
103
104
100
101
102
103
104
104
100 101 102 103 104
1.73
6.61
CT siRNA+UVB
CD
25
3
2
IL
-1
7A
 (fo
ld 
ch
an
ge
)
1
0
3.5
2.5
3.0
2.0
1.0
IL
-1
0 
(fo
ld 
ch
an
ge
)
1.5
0.0
0.5
3.5
2.5
3.0
2.0
1.0
IL
-6
 (fo
ld 
ch
an
ge
)
1.5
0.0
0.5
Da
y 7
Da
y 2
4
25
50
Ep
id
er
m
al
 th
ick
ne
ss
 (μ
m
)
75
***
***
*
*100
3
Day 7
CT
 s
iR
NA
CD
28
 s
iR
NA
Day 24
5 7 9 11 13 15 17 19 21 23
CT siRNA or CD28 siRNA given i.p.
immediately before UVB exposure
CT siRNANone
150
150
120
120
80
80
40
40
0
150
120
80
40
0
150
120
80
40
0
0 15012080400 15012080400
M
ea
n 
CP
D 
in
te
ns
ity
10
M
ea
n 
CP
D 
in
te
ns
ity
20
30
0
NER-related genes
m
R
N
A 
fo
ld
 c
ha
ng
e 
(2–
ΔΔ
CT
)
5
10
15
20
Apoptosis-related genes
CT CD28 siRNA
At
m
M
gm
t
R
ad
21
Tr
p5
3
Br
ca
1
M
lh
1
0m
R
N
A 
fo
ld
 c
ha
ng
e 
(2–
ΔΔ
CT
)
5
10
CT siRNA
CD28 siRNA
15
20
D
cl
re
1a
Fa
nc
c
N
th
l1
R
ad
23
a
Sl
k
Xp
a
Xp
c
UVB (80 mJ cm–2) UVB (220 mJ cm–2)
CT siRNA + UVB
CT siRNA
CD28 siRNA + UVB
CD28 siRNA
No UVB
Day 7 Day 24 Day 7 Day 24 Day 7 Day 24 Day 7 Day 24
CD28
siRNA
CT
siRNA
None
CD28
siRNA
CT
siRNA
None
0 Hours
0 Hours
After 24 hours, skin
biopsies collected
for analysis
24 Hours after last exposure,
mice killed for tissue collection
TP Singh et al.
In Vivo CD28 Knockdown
862 Journal of Investigative Dermatology (2014), Volume 134
exposure (data not shown). However,
we found significantly less CPD-positive
cells (mean CPD intensity±SEM of
16.0±2.2 vs. 23.4±1.3) and lower
numbers of SBCs (18.8±1.5 vs. 36.3±
2.5) 24 hours after UVB exposure in the
CD28-targeted mice compared with
the control mice (Figure 1e and f). We
have also observed less 6,4-photopro-
duct-positive cells in the epidermis of
CD28 siRNA-treated mice compared
with vehicle-treated mice (maximum
difference at day 7; Supplementary
Figure S2 online). Further, we analyzed
for DNA repair mechanisms that may
be induced directly or indirectly by
CD28 silencing. Surprisingly, we found
increased mRNA of NER-related genes
(one of the crucial DNA repair pathways
for the removal of CPDs after UVB
exposure (Cline and Hanawalt, 2003)
in CD28-targeted mice compared with
control siRNA-treated mice after UVB
exposure (Figure 1g and i). The NER
mechanism involves a multistep pro-
cess, in which the DNA lesions are
recognized and repaired by a protein
machinery. After UVB exposure, multi-
ple proteins including Xpa, Xpc, Xpg,
Rpa, Slk, Rad23a, and Rad23b direct the
NER in mammalian cells for the removal
of DNA lesions (Cline and Hanawalt,
2003; Schwarz and Schwarz, 2011). We
found that the effect of in vivo CD28
knockdown was most pronounced for
the mRNA expression of the genes Xpa,
Xpc, Slk, and Rad23a (Figure 1g and i
and Supplementary Table S1 online).
We were able to confirm this on the
protein level for XPC, as we found
increased expression in cell nuclei of
the skin from CD28 siRNA-treated mice,
as detected by immunohistochemistry
(Supplementary Figure S2 online). How-
ever, the mRNA expression of apopto-
sis-related genes was also affected, but
to a lesser degree, including Atm, Mgmt,
Rad21, Brca1, Mlh1, and the master
gene P53 which were all upregulated
in CD28-targeted mice compared with
control siRNA-treated mice, suggesting
the P53-dependent activation of DNA
repair genes (Figure 1h and Supple-
mentary Table S1 online; Offer et al.,
2002; Smith and Seo, 2002). In contrast,
the nuclear protein level of p53 was
lower in keratinocytes of the epidermis
of the CD28 siRNA-treated group as
compared with CT siRNA group
(Supplementary Figure S2 on-
line). This may be due to the decreased
overall DNA damage by early improve-
ment of DNA repair via the p53 pathway.
Moreover, posttranslational modifications
may also account for the difference.
Next, we investigated the effect of
in vivo CD28 knockdown in a chronic
UVB exposure, based on irradiation
protocol of a previous study (Pflegerl
et al., 2009). In this protocol, mice
were first injected with CD28 siRNA or
control siRNA before each exposure to 6
repetitive UVB doses of 80 mJ cm2 and
thereafter to 6 doses of 220 mJ cm2
(Figure 1j). We found significant reduc-
tion in skin hyperplasia after in vivo
CD28 knockdown (Figure 1k and l).
Skin thickness was reduced by B40%
at day 7 and by B50% at day 24 in
the CD28 siRNA-targeted group com-
pared with the control siRNA group
(Figure 1l). Further, we analyzed for
mRNA expression of inflammatory
mediators and found that in vivo CD28
knockdown significantly reduced the
level of COX2 from 2.87±0.30 to
1.36±0.31, IL-10 from 3.28±0.19 to
1.49±0.56, and IL-17A from 5.60±
1.02 to 2.18±0.56 fold expression at
day 24 (Figure 1m). Interestingly, we
also observed a reduced percentage
of UV-induced CD4þCD25þ T cells
in the lymph nodes of CD28 siRNA-
targeted mice compared with control
siRNA-injected animals (1.73 vs. 6.61)
at day 24 of the treatment proto-
col (Figure 1n). UV-induced CD4þ
CD25þhigh Tregs represent a specific
subtype of those cells and differ from
natural Tregs and other types of induced
Tregs in many ways (Clydesdale et al.,
2001; Schwarz and Schwarz, 2009,
2011).
The immediate effects of UVB in the
skin include DNA damage to keratino-
cytes and Langerhans cells (LCs) that
lead to the production and release of
immunoregulatory factors such as IL-10,
transforming growth factor-b, PGE2, and
tumor necrosis factor-a from these cells
(Clydesdale et al., 2001). Notably, these
soluble factors turn the skin environ-
ment immunosuppressive that is further
enhanced by the generation and recruit-
ment of IL-10-producing CD4þ
CD25þ Tregs (Schwarz and Schwarz,
2011). Thus, it is possible that CD28
Figure 1. In vivo CD28 knockdown diminishes UVB-induced sunburn cell formation and DNA damage and inflammation. (a) Schematic diagram showing the
treatment protocol. Wild-type mice (ICR-CD1R) were unexposed or exposed to UVB immediately after CD28 small interfering RNA (siRNA) or control siRNA (CT
siRNA) injection. Mice were killed at 24 hours after the first UVB exposure for hematoxylin and eosin (H&E) and cyclobutane pyrimidine (thymine) dimer (CPD)
staining and quantitative reverse transcription (qRT)-PCR analysis. (b) Representative photomicrographs of H&E-stained sections of dorsal skin for sunburn cell
(SBC) evaluation. Arrows depict typical SBCs with condensed nuclei and shrunken, slight eosinophilic cytoplasm. Scale bar¼ 100mm. (c) Representative
immunohistochemical stainings of dorsal skin for the evaluation of CPD. Scale bar¼ 100mm. (d) Representative plots of mean CPD intensity (y-axis) and mean
nuclear intensity (x-axis), as analyzed by tissue cell analysis. (e) Number of SBCs in H&E-stained sections in different treatment groups (n¼4 mice per group
and representative of two independent experiments, ***Po0.001). (f) Mean relative CPD intensity in different treatment groups, as measured by tissue cell
analysis (n¼ 4 mice per group and representative of two independent experiments, *Po0.05, ***Po0.001). (g) Heat map of qRT-PCR data was generated with
the R programming language. The color represents log2-transformed fold changes and indicates low (red) to high (green) values (expression values represent
pool of mRNA from n¼3 mice per group). (h, i) Fold change of apoptosis- and NER-related genes in the skin of different treatment groups (expression values
represent pool of mRNA from n¼ 3 mice per group). (j) Schematic diagram showing chronic treatment protocol over 23 days. Wild-type mice (ICR-CD1R) were
unexposed or exposed to UVB immediately after CD28 siRNA or CT siRNA injection. Mice were killed 24 hours after the first UV exposure or at days 7 and
24 for tissue collection. (k) Representative photomicrographs of H&E-stained sections of different treatment groups at different time points. Scale bar¼ 200mm.
(l) Epidermal thickness in different treatment groups at different time points (n¼4 mice per group and representative of two independent experiments, *Po0.05,
***Po0.001). (m) qRT-PCR for COX2, IL-10, IL-6, and IL-17 A mRNA of skin from different treatment groups at different time points (n¼ 3–4 mice per group
and representative of two independent experiments, *Po0.05). (n) Flow cytometry analysis of CD4þCD25þ T cells in the lymph nodes from different treatment
groups at day 24 (data represent pool of lymph nodes from n¼ 3 mice per group). i.p., intraperitoneal.
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knockdown may have altered the
immune surveillance milieu in the skin
with its complex cytokine patterns and
reduced numbers and function of Tregs,
thereby leading to the increase of NER
mechanisms and subsequent reduction
of DNA damage as measured by CPDs
(Figure 1c, d, and f). In addition, the
CD28 ligands BB-1 and B7 that are
expressed in keratinocytes provide an
important co-stimulatory signal for CD3-
mediated proliferation of T lympho-
cytes, including alloreacting CD4þ T
cells (Koulova et al., 1991; Simon et al.,
1994). This raises the possibility that
T-cell activation by keratinocytes after
UVB exposure may have been inhibited
by in vivo CD28 siRNA knockdown.
In this regard, it is interesting to note
that functional blockade of CD80/CD86
significantly decreased UV-induced
tumor development (Loser et al., 2005).
In any case, further studies are warranted
to determine the precise mechanisms by
which CD28 knockdown leads to increa-
sed NER and decreased DNA damage
and skin alterations.
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TO THE EDITOR
Oral squamous cell carcinoma occur-
ring after allogeneic hematopoietic stem
cell transplantation (HSCT/SCC) is far
rarer than tobacco- and alcohol-related
oral SCCs (common SCCs; Majhail
et al., 2011). Oral HSCT/SCC is clini-
cally and histopathologically close to
common SCCs and has a poor progno-
sis with high morbidity and mortality,
especially in Fanconi patients (Masserot
et al., 2008; Mawardi et al., 2011). It is
not alcohol- and tobacco-related but is
strongly associated with pre-existing
oral lichen planus–like eruption (LPLE;
Demarosi et al., 2005; Majhail et al.,
2011), an early characteristic feature
of chronic graft-versus-host disease
(cGVHD; Imanguli et al., 2008). LPLE
and idiopathic oral lichen planus (OLP)
are clinically and histopathologically
close (Mattsson et al., 1992). We
have previously shown that HSCT/SCC
exhibits a strong p53 expression (Socie
et al., 1998).
Here, we performed a sequential
study of p53 protein and TP53 gene
alterations in 10 patients with oral LPLE
and HSCT/SCC, compared with 10
patients with OLP and 10 patients with
common SCCs. The study aimed to
determine whether specific p53 altera-
tions were present after HSCT, at what
stage they occurred, and whether LPLE
had features of a preneoplastic disease.
The Institutional Ethics Committee
approved this study. According to the
French law, all patients were informedAccepted article preview online 4 September 2013; published online 17 October 2013
Abbreviations: cGVHD, chronic graft-versus-host disease; DNA, deoxyribonucleic acid; FISH, fluorescent
in situ hybridization; HRM-PCR, high-resolution melting PCR; HSCT, hematopoietic stem cell
transplantation; LPLE, lichen planus–like eruption; OLP, oral lichen planus; SCC, squamous cell carcinoma
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